Proteomics

Dataset Information

0

Five microRNAs in serum are able to differentiate breast cancer patients from healthy individuals


ABSTRACT: Breast Cancer is the cancer with most incidence and mortality in women. microRNAs are emerging as novel prognosis/diagnostic tools. Our aim was to identify a serum microRNA signature useful to predict cancer development. We focused on studying the expression levels of 30 microRNAs in the serum of 96 breast cancer patients versus 92 control individuals. Bioinformatic studies provide a microRNA signature, designated as a predictor, based upon the expression levels of 5 microRNAs. Then, we tested the predictor in a group of 60 randomly chosen women. Lastly, a proteomic study unveiled the over-expression and down-regulation of proteins differently expressed in the serum of breast cancer patients versus that of control individuals. Twenty-six microRNAs differentiate cancer tissue from healthy tissue and 16 microRNAs differentiate the serum of cancer patients from that of the control group. The tissue expression of miR-99a-5p, mir-497-5p, miR-362, and miR-1274, and the serum levels of miR-141 correlated with patient survival. Moreover, the predictor consisting of mir-125b-5p, miR-29c-3p, mir-16-5p, miR-1260, and miR-451a was able to differentiate breast cancer patients from controls. The predictor was validated in 20 new cases of breast cancer patients and tested in 60 volunteer women, assigning 11 out of 60 women to the cancer group. An association of low levels of mir-16-5p with a high content of CD44 protein in serum was found. Circulating microRNAs in serum can represent biomarkers for cancer prediction. Their clinical relevance and use of the predictor here described might be of potential importance for breast cancer prediction.

INSTRUMENT(S): LTQ Orbitrap

ORGANISM(S): Homo sapiens  

TISSUE(S): Blood Serum

DISEASE(S): Breast Cancer

SUBMITTER: Cristina Mir  

LAB HEAD: Matilde E. Lleonart

PROVIDER: PXD020795 | Pride | 2020-09-18

REPOSITORIES: pride

Similar Datasets

2018-01-01 | S-EPMC6454510 | BioStudies
2017-01-01 | S-EPMC5642528 | BioStudies
2018-01-01 | S-EPMC6078958 | BioStudies
2016-01-01 | S-EPMC5154569 | BioStudies
1000-01-01 | S-EPMC4546486 | BioStudies
1000-01-01 | S-EPMC5399194 | BioStudies
2019-01-01 | S-EPMC6943465 | BioStudies
1000-01-01 | S-EPMC6310725 | BioStudies
2018-01-01 | S-EPMC6021336 | BioStudies
1000-01-01 | S-EPMC5342414 | BioStudies